Sophie N. Raynal,Micheline R. Kergoat,Valerie Autier,Christine G. Charon,Jean-Denis Durand,Franck F. Lepifre,Annick M. Audet
申请号：
US15566955
公开号：
US10350184B2
申请日:
2016.04.14
申请国别(地区):
US
年份:
2019
代理人:
摘要：
This invention relates to oxime and alkoxy derivatives of the general formula (I),or an enantiomer, diastereoisomer, hydrate, solvate, tautomer, racemic mixture or pharmaceutically acceptable salt thereof for use as a medicament for the treatment and/or prevention of muscle atrophy in mammals and/or for limiting muscular atrophy in mammals and/or to promote muscle growth in exercising mammals aimed at increasing muscle mass and quality, preventing the occurrence of symptoms of sarcopenia related to age or rehabilitation after a muscle loss, age-related muscle atrophy and/or the consequences of drug therapy and/or immobilization and/or cachexia.
